Histological and histochemical alterations in the normal breast tissues of patients with advanced breast cancer being treated with estrogenic hormones

R. A. Huseby,L. Thomas

DOI: https://doi.org/10.1002/1097-0142(195401)7:1<54::AID-CNCR2820070108>3.0.CO;2-5

IF: 6.9209

1954-01-01

Cancer

Abstract:EVERAL YEARS have elapsed since the first S demonstration that the administration of relatively large doses of estrogenic substances to postmenopausal women may result in a dramatic regression of established breast can~ e r . 1 ~ This therapy is now in very general use, but there still exists no rational explanation based on clinical experimentation or observation for this seemingly paradoxical therapeutic regimen. In 1940 Zondek published an account of an unsuccessful attempt to inhibit the growth of breast cancer in a young woman by the administration of relatively large doses of estradiol benzoate. His rationale lay, in part, in the experimental work indicating that administration of large doses of estrogen to young animals produced “dwarfing by inhibiting the release of growth hormone of the anterior pituitary,” in the already abundant work indicating that transplanted animal tumors either failed to “take” or grew more slowly in hypophysectomized animals, and in the suggestion that the pituitary growth hormone might possibly be involved in such in-